ADDITIONAL FIRST QUARTER AND RECENT HIGHLIGHTS:
-- Reached agreements with the DEA and seven U.S. Attorneys' Offices that resulted in reinstated licenses to distribute controlled substances from the company's Auburn, Wash., Lakeland, Fla. and Swedesboro, N.J. distribution centers.
-- Completed the sale of the company's MedSystems and Tecomet businesses, which were non-strategic assets from the VIASYS acquisition.
-- Hosted approximately 400 health care industry leaders at the inaugural Chasing Zero Summit to encourage a zero-tolerance approach to health care associated infections (HAIs).
-- Signed 50 new customers for MedMined(TM) services, the market leader in electronic infection surveillance.
-- The Cardinal Health Foundation launched the second annual $1 million Patient Safety Grant to help U.S. hospitals, health systems and community health clinics improve patient safety and health care quality.
-- Launched myPharmacyTrainer, a proprietary online training site that helps independent pharmacies coach their employees to deliver better patient care, improve customer loyalty and increase sales.
Cardinal Health's guidance range for the full year remains unchanged at
$3.80 to $3.95 for non-GAAP diluted EPS from continuing operations. Clark
said, "It is clear that we are operating in an unprecedented economic
environment, yet Cardinal Health remains well positioned with a strong
balance sheet that enables ongoing access to capital. While we have not
|SOURCE Cardinal Health, Inc.|
Copyright©2008 PR Newswire.
All rights reserved